People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Pharmaceuticals, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arthrosi Therapeutics, Inc. | — | Pharmaceuticals | Series C | $132.9M | $385.6M | 2023 |
| Clover Biopharmaceuticals, Ltd. | — | Biotechnology | Series C | $49.8M | $8.9M | 2021 |
Xiaodong Wang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Xiaodong Wang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Orr | 1 | 7 |
| THOMAS HUANG | 1 | 4 |
| James Mackay | 1 | 4 |
| Chaohua Yuan | 1 | 1 |
| John Leaman | 1 | 1 |
| Hanxiong Li | 1 | 1 |
| Xin Xie | 1 | 1 |
| Litain Yeh | 1 | 1 |
| Shunqi Yan | 1 | 1 |
| James McKay | 1 | 1 |
| Xiaojia Cai | 1 | 1 |
| Yiwei Zong | 1 | 1 |
| Zhang Mingyuan | 1 | 1 |
| Cynthia Cai | 1 | 1 |
| Xie Xin | 1 | 1 |
| Yiwei Zhong | 1 | 1 |
| Li Hanxiong | 1 | 1 |
| Jianhua Cai | 1 | 1 |
| Jianfeng Fang | 1 | 1 |
| Joshua Liang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.